myozyme 52.5 mg
شركة ألفه للأدوية - ulfa pharma co. - alglucosidase alfa (rhgaa) 52.5 mg - 52.5 mg
myozyme 50mg powder for concentrate for solution for infusion
genzyme europe b.v., netherlands - alglucosidase alfa - powder for concentrate for solution for infusion - 5 mg/ml
myozyme
genzyme australasia pty ltd - alglucosidase alfa -
myozyme
genzyme australasia pty ltd - alglucosidase alfa -
opfolda
amicus therapeutics europe limited - miglustat - glycogen storage disease type ii - other alimentary tract and metabolism products - opfolda (miglustat) is an enzyme stabiliser of cipaglucosidase alfa long-term enzyme replacement therapy in adults with late-onset pompe disease (acid α- glucosidase [gaa] deficiency).